p-Aminosalicylic acid (PAS) is an antibiotic used to treat tuberculosis. It is also used to treat other infections, such as leprosy and schistosomiasis. PAS is available as a tablet, capsule, or suspension. The global market for p-Aminosalicylic acid is expected to grow at a CAGR of 3.5% from 2022 to 2028. This growth is being driven by the increasing prevalence of tuberculosis, the rising demand for generic drugs, and the increasing number of clinical trials for PAS. The main buyers of p-Aminosalicylic acid are pharmaceutical companies, hospitals, clinics, and research institutes. The pharmaceutical companies are the major buyers of PAS, as they use it to manufacture their own products. Hospitals…